MoneyWorks4Me

Venus Remedies - Quaterly Results

30 Jul 2022 Evaluate
The revenue for the June 2022 quarter is pegged at Rs. 1549.30 millions, about 13.21% up against Rs. 1368.50 millions recorded during the year-ago period.Net profit declined -23.99% to Rs. 110.90 millions from Rs. 145.90 millions.The company reported a degrowth in operating Profit to 196.60 millions from 212.70 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 1549.30 1368.50 13.21 1549.30 1368.50 13.21 5751.81 5146.23 11.77
Other Income 14.10 19.20 -26.56 14.10 19.20 -26.56 84.29 177.62 -52.54
PBIDT 196.60 212.70 -7.57 196.60 212.70 -7.57 772.50 646.25 19.54
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 127.26 -100.00
PBDT 196.60 212.70 -7.57 196.60 212.70 -7.57 772.50 753.41 2.53
Depreciation 75.70 83.60 -9.45 75.70 83.60 -9.45 325.80 342.80 -4.96
PBT 120.90 129.10 -6.35 120.90 129.10 -6.35 446.70 410.61 8.79
TAX 10.00 -16.80 -159.52 10.00 -16.80 -159.52 -43.16 -132.12 -67.33
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 110.90 145.90 -23.99 110.90 145.90 -23.99 489.86 542.73 -9.74
Equity 133.70 133.67 0.02 133.70 133.67 0.02 133.67 123.42 8.30
PBIDTM(%) 12.69 15.54 -18.36 12.69 15.54 -18.36 13.43 12.56 6.95
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..